• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by Akso Health Group

    5/1/25 4:35:34 PM ET
    $AHG
    Business Services
    Consumer Discretionary
    Get the next $AHG alert in real time by email
    6-K 1 ea0240531-6k_aksohealth.htm REPORT OF FOREIGN PRIVATE ISSUER

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 6-K

     

    REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE

    SECURITIES EXCHANGE ACT OF 1934

     

    For the month of May 2025

     

    Commission File Number: 001-38245

     

    Akso Health Group

    (Exact name of registrant as specified in its charter)

     

    Room 8201-4-4(A), 2nd Floor, Qiantongyuan Building,

    No. 44, Moscow Road, Qianwan Bonded Port Area,

    Qingdao Pilot Free Trade Zone, China (Shandong)

    Tel: +86 152 1005 4919

    (Address of Principal Executive Offices)

     

    Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

     

    Form 20-F ☒            Form 40-F ☐

     

     

     

     

     

     

    Change of Chief Financial Officer

     

    On April 24, 2025, Ms. Rui (Kerrie) Zhang notified Akso Health Group (the “Company”) of her resignation as Chief Financial Officer (“CFO”) of the Company, effective as of April 24, 2025. Ms. Rui (Kerrie) Zhang has advised the Company that her resignation was due to personal reasons and not a result of any disagreement with the Company on any matter related to the operations, policies, or practices of the Company.  

     

    To fill the vacancy created by Ms. Rui (Kerrie) Zhang’s departure, the Board of Directors of the Company appointed Mr. Zhongliang Xie as CFO, effective April 24, 2025. The appointment of Mr. Xie as CFO has a term of one year and may be extended for successive one-year terms, subject to earlier resignation or removal. The biographical information of Mr. Xie is set forth below.

     

    Mr. Zhongliang Xie has served as the General Manager of Zhongxingcai Guanghua Certified Public Accountants Shaanxi Branch since 2019. He previously served as the General Manager of Beijing Xinghua Certified Public Accountants Xi’an Branch from 2008 to 2018, and as the Finance Manager of Zhongyi Far East Import & Export Co., Ltd. from 2005 to 2008. Mr. Xie has also been the signing CPA and lead audit partner for several bond issuance and annual report projects in China. In addition, he has served as the lead audit partner for the listing and annual reports of numerous companies listed on the National Equities Exchange and Quotations (NEEQ) of China. Mr. Xie is a Chinese Certified Public Accountant (CPA), Certified Asset Appraiser, Chinese Certified Cost Engineer, and a fellow of the International Association of Accountants (FAIA).

     

    There are no family relationships between Mr. Zhongliang Xie and any director of the Company. To the best knowledge of the Company, there is no understanding or arrangement between Mr. Xie and any other person pursuant to which he was appointed as the CFO of the Company. 

     

    1

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

      Akso Health Group
       
      By: /s/ Yilin (Linda) Wang
      Name:  Yilin (Linda) Wang
      Title: Chief Executive Officer
       
    Date: May 1, 2025  

     

     

    2

     

    Get the next $AHG alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AHG

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $AHG
    SEC Filings

    See more
    • Amendment: SEC Form F-3/A filed by Akso Health Group

      F-3/A - Akso Health Group (0001702318) (Filer)

      5/22/25 5:20:31 PM ET
      $AHG
      Business Services
      Consumer Discretionary
    • SEC Form 6-K filed by Akso Health Group

      6-K - Akso Health Group (0001702318) (Filer)

      5/1/25 4:35:34 PM ET
      $AHG
      Business Services
      Consumer Discretionary
    • SEC Form 6-K filed by Akso Health Group

      6-K - Akso Health Group (0001702318) (Filer)

      3/28/25 4:05:19 PM ET
      $AHG
      Business Services
      Consumer Discretionary

    $AHG
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • AHG Utilizes DeepSeek to Advance AI in Healthcare

      QINGDAO, China, Feb. 18, 2025 /PRNewswire/ -- Akso Health Group (NASDAQ:AHG) (hereinafter referred to as "Akso Health," "the Company," or "we") announced today its integration of DeepSeek's advanced artificial intelligence technology. This initiative aims to further enhance AI-powered medical consultation, optimize healthcare resource allocation, and provide users with more precise and efficient medical services. The utilization of DeepSeek not only represents a significant breakthrough in the field of AI-driven healthcare but also sets a new benchmark for the industry's intelligent transformation. As an innovative medical technology company, AHG leverages DeepSeek's multimodal large-scale

      2/18/25 8:30:00 AM ET
      $AHG
      Business Services
      Consumer Discretionary
    • AHG Announces Plan to Acquire Online Clinic

      QINGDAO CHINA, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Akso Health Group (NASDAQ:AHG) ( "Akso Health," "the Company," or "we") today announced its plan to make an equity investment in Deyihui, an online clinic based in China. Akso Health plans to tap into the online clinic business initially in China and if the results are satisfactory, to expand this business to the other countries and regions.  Given the rapid growth of virtual consultations in mainland China, management believes this is a significant untapped market where the Company may leverage its capital resources as well as first-move advantage. The planned equity investment in Deyuhui is expected to aid management in getting famili

      1/31/24 4:00:00 PM ET
      $AHG
      Business Services
      Consumer Discretionary
    • Akso Health Group Regains Compliance with Nasdaq's Minimum Bid Price Requirement

      BEIJING, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Akso Health Group (NASDAQ:AHG) ("Akso Health" the "Company" or "we"), announced today that on October 11, 2023, it received a letter from the Nasdaq Listing Qualifications Department notifying the Company that it had regained compliance with the minimum bid price requirement. On October 26, 2022, the Company received a notification that it's American Depositary Shares ("ADS") failed to maintain a minimum bid price of $1.00 over the previous 30 consecutive business days, as required by Nasdaq Listing Rules of The Nasdaq Stock Market. The closing bid price of the Company's ADS was at $1.00 per share or greater from September 15, 2023 to October 10,

      10/16/23 10:30:00 AM ET
      $AHG
      Business Services
      Consumer Discretionary